Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study.
Piroxicam 20 mg daily was compared with naproxen 1000 mg daily in a double-blind cross-over study of 24 patients with rheumatoid arthritis. A comparison was also made with the pre-trial medication. The effect of the pre-trial medication, piroxicam and naproxen, were found to be similar. The side-effects of piroxicam and naproxen were similar and mild.
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000627:therapeutic use*; D010894:Piroxicam; D013843:Thiazines / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D013843:Thiazines; D010894:Piroxicam; D009288:Naproxen